iCoreConnect Inc. - FGMC STOCK NEWS

FG Merger Corp. (NASDAQ: FGMC) is introducing a unique investment opportunity that allows retail investors access to securities typically reserved for institutional investors. Following its upcoming business combination with iCoreConnect Inc., FG Merger Corp. will offer convertible preferred stock with a 12% coupon, payable in shares or cash. Investors will also benefit from downside protection during the first year, with a dynamic conversion price based on stock performance. This structure is akin to a Private Investment In Public Equity (PIPE) deal, allowing retail investors to buy shares through standard brokerage accounts. The initiative seeks to level the playing field in the stock market, aiming for greater inclusivity among investors.

Intrinsic LLC, a valuation and transaction advisory firm, announced it issued two fairness opinions for publicly traded clients in 2022. The firm provided an opinion to Zynex Inc. (Nasdaq: ZYXI) affirming that $31 million for acquiring Kestrel Labs was fair. Additionally, for FG Merger Corp (Nasdaq: FGMC), it deemed $100 million in a merger with iCoreConnect, Inc. fair. Intrinsic's Transaction Opinions practice supports Boards of Directors in fulfilling fiduciary duties, particularly amid evolving legal and regulatory landscapes. The firm is bolstered by a team with extensive experience in rendering fiduciary opinions across various sectors.

FG Merger Corp. (FGMC) and iCoreConnect have agreed to a business combination, valuing iCoreConnect at a pro forma enterprise value of $98 million. This merger aims to uplift iCoreConnect from OTC to Nasdaq, trading as ICCT. The combined entity anticipates gross proceeds of up to $82.5 million from FGMC's trust account, assuming no redemptions. Existing FGMC shareholders will convert their equity into preferred stock with a 12% coupon for the first two years. Both companies expect to finalize the transaction by Q2 2023, pending shareholder approval.

FG Merger Corp. (FGMC) announced a business combination with iCoreConnect, valuing iCoreConnect at $98 million. This merger will facilitate iCoreConnect's transition from OTC to Nasdaq under the symbol ICCT. Existing FGMC shareholders can convert their equity into preferred stock with a 12% coupon for the first two years. iCoreConnect, a SaaS provider, has seen a 65% revenue CAGR since 2018, projected to achieve $8.1 million revenue in 2022. The merger aims to leverage healthcare technology trends and significant market potential.